A group of LPs including fund-of-funds manager Clearsight Investments has removed Varova NL as the manager of its special situations fund and replaced it with turnaround firm Standard Investment.
Also backing the biotech startup were the Zürcher Kantonalbank and Greencross Medical Science Corp
Company plans to use the fresh capital to further expand, develop new features and scale up its team
EVentures, 468 Capital and HV Holtzbrinck back the round for the climate change mitigation app
Clessidra has been in negotiations for the acquisition of the Italian wine producer since February 2020